ZURA Zura Bio Limited

Fundamentals / CIK 0001855644 / USD

Zura Bio Limited reported $194.6M in total assets and a net loss of $93.53M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZURA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$64.19MFY 2022 Net Income: -$25.74M2022FY 2023 Net Income: -$60.36M2023FY 2024 Net Income: -$52.40M2024FY 2025 Net Income: -$68.65M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $42.08M $24.40M $44.00M $23.69M
Total Operating Expenses $75.25M $55.19M $62.64M $27.16M
Operating Income -$75.25M -$55.19M -$62.64M -$27.16M
EBITDA -$75.20M -$55.18M -- --
Interest Income $6.34M $8.00M $2.19M $8.0K
Income Before Tax -$68.65M -$52.40M -$60.56M -$27.33M
Income Tax Expense -- $0 $0 --
Net Income -$68.65M -$52.40M -$60.36M -$25.74M
Basic EPS -$1.06 -$0.60 -$2.09 -$141.97
Diluted EPS -$1.06 -$0.60 -$2.09 -$141.97
Basic Shares Outstanding 94.2M 75.1M 33.1M 228.1K
Diluted Shares Outstanding 94.2M 75.1M 33.1M 228.1K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $19.49M $20.71M $14.75M $10.96M $11.95M $8.70M $10.47M $9.24M
Total Operating Expenses $28.77M $29.32M $25.50M $18.41M $19.52M $18.06M $19.25M $15.73M
Operating Income -$28.77M -$29.32M -$25.50M -$18.41M -$19.52M -$18.06M -$19.25M -$15.73M
EBITDA -$28.77M -$29.34M -$25.48M -$18.36M -$19.52M -$18.07M -$19.25M --
Interest Income $1.76M $1.92M $1.32M $1.28M $1.53M $1.72M $1.82M $2.13M
Income Before Tax -$27.05M -$26.39M -$24.22M -$17.18M -$18.04M -$15.99M -$17.44M -$13.62M
Income Tax Expense -$1.22M -$81K $0 -- $0 $0 $0 --
Net Income -$25.82M -$26.30M -$24.22M -$17.18M -$18.04M -$15.99M -$17.44M -$13.62M
Basic EPS -$0.20 -$0.21 -$0.22 -- -$0.21 -$0.17 -$0.19 --
Diluted EPS -$0.20 -$0.21 -$0.22 -- -$0.21 -$0.17 -$0.19 --
Basic Shares Outstanding 127.7M 126.8M 112.2M -- 94.6M 94.3M 93.0M --
Diluted Shares Outstanding 127.7M 126.8M 112.2M -- 94.6M 94.3M 93.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $109.4M $176.5M $99.81M $14K $729K
Cash & Short-Term Investments $109.4M $176.5M $99.81M $14K $729K
Total Current Assets $112.3M $178.7M $100.8M $1.78M $1.15M
Property, Plant & Equipment, Net $126K $91K -- -- --
Other Non-Current Assets $1.51M $698K -- -- --
Total Non-Current Assets $1.64M $789K $0 $3.49M $139.4M
Total Assets $113.9M $179.5M $100.8M $5.26M $140.6M
Accounts Payable $1.28M $733K $2.75M $2.01M $70K
Total Current Liabilities $12.41M $19.51M $20.30M $14.82M $272K
Total Non-Current Liabilities $0 $0 $990K $0 $10.08M
Total Liabilities $12.41M $19.51M $21.29M $14.82M $10.35M
Common Stock $7.0K $7.0K $4.0K -- --
Retained Earnings -$224.5M -$155.9M -$103.5M -$32.06M -$9.18M
Total Stockholders' Equity $101.5M $146.8M $59.33M -$32.06M -$9.18M
Total Equity $101.5M $148.4M $60.87M -$32.06M -$9.18M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $187.7M $205.1M $225.6M $109.4M $139.0M $154.5M $170.6M $176.5M
Cash & Short-Term Investments $187.7M $205.1M $225.6M $109.4M $139.0M $154.5M $170.6M $176.5M
Total Current Assets $191.6M $210.5M $227.0M $112.3M $142.3M $157.0M $171.7M $178.7M
Property, Plant & Equipment, Net $153K $149K $125K $126K $131K $122K $106K $91K
Other Non-Current Assets $2.88M $2.75M $1.51M $1.51M $1.51M $698K $698K $698K
Total Non-Current Assets $3.04M $2.90M $1.64M $1.64M $1.64M $820K $804K $789K
Total Assets $194.6M $213.4M $228.6M $113.9M $143.9M $157.8M $172.5M $179.5M
Accounts Payable $758K $3.28M $2.08M $1.28M $3.27M $1.21M $1.25M $733K
Total Current Liabilities $16.97M $16.32M $11.74M $12.41M $25.49M $18.70M $21.09M $19.51M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $16.97M $16.32M $11.74M $12.41M $25.49M $18.70M $21.09M $19.51M
Common Stock $10K $10K $9.0K $7.0K $7.0K $6.0K $7.0K $7.0K
Retained Earnings -$300.9M -$275.1M -$248.8M -$224.5M -$207.4M -$189.3M -$173.3M -$155.9M
Total Stockholders' Equity -- -- -- $101.5M $108.2M $125.9M $138.2M $146.8M
Total Equity $177.7M $197.1M $216.9M $101.5M $109.8M $127.4M $139.7M $148.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$68.65M -$52.40M -$60.56M -$27.33M
Depreciation & Amortization $49K $9.0K -- --
Stock-Based Compensation $12.33M $16.80M $7.47M $334K
Change in Payables -- -- -- $212K
Operating Cash Flow -$64.81M -$28.08M -$15.05M -$1.20M
Capital Expenditure -$113K -$75K -- --
Free Cash Flow -$64.93M -$28.15M -- --
Investing Cash Flow -$113K -$5.08M -$8.00M -$12.00M
Common Stock Issued -- -- $56.68M --
Financing Cash Flow -$2.16M $109.8M $121.3M $14.77M
Net Change in Cash -$67.09M $76.69M $98.24M -$715K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$26K $24.17M -$24.22M -$68.60M -$18K $17.41M -$17.44M -$13.62M
Depreciation & Amortization $20 -$16K $16K $49K $14 -$9.0K $9.0K --
Stock-Based Compensation $5.3K -$5.00M $5.01M $12.32M $2.4K -$3.64M $3.64M $2.82M
Operating Cash Flow -$19K $18.88M -$18.92M -$64.77M -$15K $11.04M -$11.06M -$10.82M
Capital Expenditure -$36 $13K -$13K -$113K -$32 $49K -$49K -$45K
Free Cash Flow -$20K $18.90M -$18.94M -$64.89M -$15K $11.08M -$11.11M -$10.87M
Investing Cash Flow -$36 $13K -$13K -$113K -$32 $49K -$49K -$45K
Financing Cash Flow $2.1K -$135.0M $135.1M -$2.17M $3 -$5.18M $5.18M --
Net Change in Cash -$17K -$116.1M $116.2M -$67.05M -$15K $5.91M -$5.93M -$11.72M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -67.6% -35.7% -101.7% --
Return on Assets (ROA) -60.2% -29.2% -59.9% -489.1%
Current Ratio 9.05x 9.16x 4.97x 0.12x
Quick Ratio 8.82x 9.04x 4.92x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -67.6% -60.1% -53.8% -44.9% -35.7%
Return on Assets (ROA) -48.1% -40.2% -33.0% -60.2% -45.2% -42.9% -36.0% -29.2%
Current Ratio 11.29x 12.90x 19.33x 9.05x 5.58x 8.40x 8.14x 9.16x
Quick Ratio 11.06x 12.57x 19.21x 8.82x 5.45x 8.26x 8.09x 9.04x
Operating Cash Flow Growth (YoY) -- +71.1% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- +70.5% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001855644) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal